{"id":1856,"date":"2008-10-01T01:00:00","date_gmt":"2008-10-01T00:00:00","guid":{"rendered":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/"},"modified":"2018-10-20T18:39:48","modified_gmt":"2018-10-20T16:39:48","slug":"prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel","status":"publish","type":"post","link":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/","title":{"rendered":"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel"},"content":{"rendered":"<p><strong>2008<\/strong><\/p>\n<p><em>JF Cadranel, V.Ratziu, G. Perlemuter, L. Serfaty, J. Denis, P. Delasalle, X. Causse, C. Renou, F. Roudot-Thoraval, M. Lombard, C. Bernardt, pour l\u2019ANGH et le CREGG.<\/em><\/p>\n<p><strong>H\u00e9patologie <\/strong>&#8211; \u00a02008-09-07 &#8211;\u00a0CO &#8211;<\/p>\n<p>________________________________<\/p>\n<p>Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel<\/p>\n<p> JF Cadranel, V.Ratziu, G. Perlemuter, L. Serfaty, J. Denis, P. Delasalle, X. Causse, C. Renou, F. Roudot-Thoraval, M. Lombard, C. Bernardt, pour l\u2019ANGH et le CREGG.<\/p>\n<p>La pr\u00e9valence de la st\u00e9atoh\u00e9patite non alcoolique (NASH) est en forte hausse en France mais n\u2019a jamais fait l\u2019objet d\u2019\u00e9valuations. Le but de cette enqu\u00eate est de conna\u00eetre les pratiques diagnostiques et th\u00e9rapeutiques des h\u00e9patogastroent\u00e9rologues (HGE) en France.<br \/>\nM\u00e9thode: un questionnaire anonyme a \u00e9t\u00e9 adress\u00e9 aux HGE de l\u2019AFEF, de l\u2019ANGH et du CREGG. 4 th\u00e8mes ont \u00e9t\u00e9 abord\u00e9s: mode de recrutement et gravit\u00e9 per\u00e7ue, r\u00e9seaux de soins, mode de diagnostic et traitement.<br \/>\nR\u00e9sultats: 351 HGE, en majorit\u00e9 de CHG puis de CHU ont r\u00e9pondu. 90% consid\u00e8rent la NASH potentiellement grave et la cirrhose NASH aussi grave que la cirrhose VHC. Les patients sont principalement adress\u00e9s par les g\u00e9n\u00e9ralistes. L\u2019HGE a parfois (38%) ou tr\u00e8s souvent (79%) recours \u00e0 un endocrinologue pour les comorbidit\u00e9s. La NASH est \u00e9voqu\u00e9e le plus souvent en cas de st\u00e9atose avec transaminases \u00e9lev\u00e9es ou chez un patient diab\u00e9tique avec bilan h\u00e9patique perturb\u00e9. 50% des HGE excluent la NASH chez l\u2019homme 35% chez la femme pour une consommation d\u2019alcool respectivement &gt;40g\/j et 30g\/j. La biopsie h\u00e9patique (PBH) a un double int\u00e9r\u00eat: rechercher une NASH et quantifier de la fibrose. L\u2019\u00e9valuation clinico-biologique comprend principalement: IMC, pression art\u00e9rielle, glyc\u00e9mie, triglyc\u00e9rides, HDL-cholest\u00e9rol mais pas insulin\u00e9mie ni HOMA. 21% \u00e9valuent l\u2019atteinte h\u00e9patique par \u00e9lastom\u00e9trie seule, 26% par biomarqueurs seuls et 41% par les deux. Une PBH est propos\u00e9e par 43% des HGE en cas de st\u00e9atose avec transaminases \u00e9lev\u00e9es et par 6% en cas de st\u00e9atose avec transaminases normales. La PBH est propos\u00e9e d\u2019embl\u00e9e (24%) ou apr\u00e8s une tentative de r\u00e9gime(62%). 15% la proposent devant toute st\u00e9atose avec transaminases \u00e9lev\u00e9es, 18% en cas de facteurs de risque clinque de fibrose, 15% si les m\u00e9thodes non invasives montrent une fibrose et 23% en cas de discordance des m\u00e9thodes non invasives. 22% des patients la refusent. Le suivi est assur\u00e9 par l\u2019HGE dans 73% des cas et par les moyens suivants: bilan h\u00e9patique(97%), glyc\u00e9mie(84%), insulin\u00e9mie(16%), bilan lipidique(74%), ferritin\u00e9mie(53%), marqueurs de fibrose(45%), \u00e9chographie h\u00e9patique(55%), PBH(4%). Plus de 40% des HGE interdisent toute consommation d\u2019alcool. Les traitements sp\u00e9cifiques les plus propos\u00e9s sont: acide ursodesoxycholique(53%), metformine(58%), glitazones(42%). Le crit\u00e8re d\u2019efficacit\u00e9 le plus retenu est la normalisation des transaminases.<br \/>\nConclusion: il existe un consensus sur le mode de diagnostique et la gravit\u00e9 potentielle de la NASH. En revanche, une h\u00e9t\u00e9rog\u00e9nit\u00e9 apparait sur: 1)la biologie \u00e0 r\u00e9aliser (int\u00e9r\u00eat de l\u2019insulin\u00e9mie, du HOMA ?); 2)les m\u00e9thodes d\u2019\u00e9valuation de l\u2019atteinte h\u00e9patique (biomarqueurs, \u00e9lastom\u00e9trie, indications de la PBH ?) ; 3)la place des traitements pharmacologiques. Afin d\u2019homog\u00e9n\u00e9iser les pratiques, cette enqu\u00eate devrait conduire \u00e0 cr\u00e9er un consensus ou bien des recommandations par les soci\u00e9t\u00e9s savantes pour la prise en charge diagnostique et th\u00e9rapeutique de la NASH.<br \/>\nRemerciements aux laboratoires Roche, Axcan et Astellas pour leur soutien \u00e0 ce projet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2008 JF Cadranel, V.Ratziu, G. Perlemuter, L. Serfaty, J. Denis, P. Delasalle, X. Causse, C. Renou, F. Roudot-Thoraval, M. Lombard, C. Bernardt, pour l\u2019ANGH et le CREGG. H\u00e9patologie &#8211; \u00a02008-09-07 &#8211;\u00a0CO &#8211; ________________________________ Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel JF Cadranel, V.Ratziu, G. Perlemuter, L. Serfaty, J. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[19],"class_list":["post-1856","post","type-post","status-publish","format-standard","hentry","category-hepatologie","tag-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel - Abstracts des congr\u00e8s de l&#039;ANGH<\/title>\n<meta name=\"description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel - Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"og:description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\" \/>\n<meta property=\"og:site_name\" content=\"Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\" \/>\n<meta property=\"article:published_time\" content=\"2008-10-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-20T16:39:48+00:00\" \/>\n<meta name=\"author\" content=\"abstracts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"abstracts\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\"},\"author\":{\"name\":\"abstracts\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\"},\"headline\":\"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel\",\"datePublished\":\"2008-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:39:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\"},\"wordCount\":618,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"keywords\":[\"2008\"],\"articleSection\":[\"Hepatologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\",\"url\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\",\"name\":\"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel - Abstracts des congr\u00e8s de l&#039;ANGH\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#website\"},\"datePublished\":\"2008-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:39:48+00:00\",\"description\":\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\",\"breadcrumb\":{\"@id\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/angh.net\/abstracts\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/angh.net\/abstracts\/#website\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"name\":\"Abstracts des congr\u00e8s de l&#039;ANGH\",\"description\":\"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003\",\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/angh.net\/abstracts\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\",\"name\":\"ANGH\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"contentUrl\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"width\":48,\"height\":18,\"caption\":\"ANGH\"},\"image\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\",\"name\":\"abstracts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"caption\":\"abstracts\"},\"url\":\"https:\/\/angh.net\/abstracts\/author\/abstracts\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel - Abstracts des congr\u00e8s de l&#039;ANGH","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/","og_locale":"fr_FR","og_type":"article","og_title":"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel - Abstracts des congr\u00e8s de l&#039;ANGH","og_description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","og_url":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/","og_site_name":"Abstracts des congr\u00e8s de l&#039;ANGH","article_publisher":"https:\/\/www.facebook.com\/ANGH-2136322560030484\/","article_published_time":"2008-10-01T00:00:00+00:00","article_modified_time":"2018-10-20T16:39:48+00:00","author":"abstracts","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"abstracts","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/#article","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/"},"author":{"name":"abstracts","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1"},"headline":"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel","datePublished":"2008-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:39:48+00:00","mainEntityOfPage":{"@id":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/"},"wordCount":618,"commentCount":0,"publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"keywords":["2008"],"articleSection":["Hepatologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/","url":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/","name":"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel - Abstracts des congr\u00e8s de l&#039;ANGH","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/#website"},"datePublished":"2008-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:39:48+00:00","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","breadcrumb":{"@id":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/angh.net\/abstracts\/prise-en-charge-de-la-steatohepatite-non-alcoolique-en-france-resultats-de-lenquete-pastel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/angh.net\/abstracts\/"},{"@type":"ListItem","position":2,"name":"Prise en charge de la st\u00e9atoh\u00e9patite non alcoolique en France: r\u00e9sultats de l\u2019enqu\u00eate Pastel"}]},{"@type":"WebSite","@id":"https:\/\/angh.net\/abstracts\/#website","url":"https:\/\/angh.net\/abstracts\/","name":"Abstracts des congr\u00e8s de l&#039;ANGH","description":"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003","publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/angh.net\/abstracts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/angh.net\/abstracts\/#organization","name":"ANGH","url":"https:\/\/angh.net\/abstracts\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/","url":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","contentUrl":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","width":48,"height":18,"caption":"ANGH"},"image":{"@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ANGH-2136322560030484\/"]},{"@type":"Person","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1","name":"abstracts","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","caption":"abstracts"},"url":"https:\/\/angh.net\/abstracts\/author\/abstracts\/"}]}},"_links":{"self":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/1856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/comments?post=1856"}],"version-history":[{"count":0,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/1856\/revisions"}],"wp:attachment":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/media?parent=1856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/categories?post=1856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/tags?post=1856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}